Varicose veins have a thickening wall. Their smooth muscle cells are disorganized as regards proliferation and production of extracellular matrix protein. An imbalance between the synthesis of collagen type I protein (collagen I) and collagen type III protein (collagen III) could explain the lack of elasticity of varicose veins. Therefore, collagen synthesis was compared in the media and in cultured smooth muscle cells derived from human control and varicose saphenous veins. An increase in total collagen synthesis was observed in the media and in smooth muscle cells derived from varicose veins. This augmentation was due to an overproduction of collagen I in cultured cells from varicose veins consistent with an increase in the release of collagen I metabolites in the media. A concomitant decrease in collagen III was observed in cultures of smooth muscle cells from varicose veins. The increase in the synthesis of collagen I in cells from varicose veins was correlated with an overexpression of the gene since mRNAs for collagen I were augmented without change in mRNA-half-life. This augmentation in the synthesis of collagen I was reduced by the addition of exogenous collagen III in cultures from varicose veins. These findings suggest a dysregulation of the synthesis of collagen I and III in smooth muscle cells derived from varicose veins.

Keywords:
Smooth muscle cells, Varicose veins, Collagens type I, III and V, Tissue elasticity and rigidity
1.
Rose SS, Ahmed A: Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg 1986;27:534–543.
2.
Psaila JV, Melhuish J: Viscoelastic properties and collagen content of the long saphenous vein in normal and varicose veins. Br J Surg 1989;76:37–40.
3.
Venturi M, Bonavina L, Annoni F, Colombo L, Butera C, Peracchia A, Mussini E: Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res 1996;60:245–248.
4.
Vanhoutte PM, Corcaud S, de Montrion C: Venous disease: From pathophysiology to quality of life. Angiology 1997;48:559–567.
5.
Gandhi RH, Irizarry A, Nackman GB, Halpern VJ, Mulcare RJ, Tilson MD: Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993;18:814–820.
6.
Lethias C, Labourdette L, Willems R, Comte J, Herbage D: Composition and organization of the extracellular matrix of vein walls: collagen networks. Int Angiol 1996;15:104–113.
7.
Maurel E, Azema C, Deloly J, Bouissou H: Collagen of the normal and the varicose human saphenous vein: A biochemical study. Clin Chim Acta 1990;193:27–38.
8.
Waksman Y, Mashiah A, Hod I, Rose SS, Friedman A: Collagen subtype pattern in normal and varicose saphenous veins in human. Isr J Med Sci 1997;33:81–86.
9.
Jurukova Z, Milenkov C: Ultrastructural evidence for collagen degradation in the walls of varicose veins. Exp Mol Pathol 1982;37:37–47.
10.
Travers JP, Dalton CM, Baker DM, Makin GS: Biochemical and histological analysis of collagen and elastin content and smooth muscle density in normal and varicose veins. Phlebology 1992;7:97–100.
11.
Kielty CM, Hopkinson I, Grant ME: Collagen: The collagen family: Structure, assembly and organization in the extracellular matrix; in Royce PM, Steinmann B (eds): Connective tissue and its heritable disorders: Molecular, genetic and medical aspects. New York, Wiley-Liss, 1993, pp 103–147.
12.
Cornu-Thenard A, Boivin P, Baud JM, De Vincenzi I, Carpentier PH: Importance of the familial factor in varicose disease. J Dermatol Surg Oncol 1994;20:318–326.
13.
Guo Q, Guo C: Genetic analysis of varicose vein of lower extremities (in Chinese). Chung Hua I Hsueh I Chuan Hsueh Tsa Chih 1998;15:221–223.
14.
Zsoter T, Cronin RF: Venous distensibility in patients with varicose veins. Can Med Assoc J 1966;94:1293–1297.
15.
Shepherd JT, Vanhoutte PM: Veins and their control. Philadelphia, Saunders, 1975, pp 1–269.
16.
Sansilvestri-Morel P, Nonotte I, Fournet-Bourguignon MP, Rupin A, Fabiani JN, Verbeuren TJ, Vanhoutte PM: Abnormal deposition of extracellular matrix proteins by cultured smooth muscle cells from human varicose veins. J Vasc Res 1998;35:115–123.
17.
O’Donell TF: Clinical diagnosis and classification of chronic venous insufficiency; in Rutherford RB (ed): Vascular Biology. Philadelphia, Saunders, 1989, pp 522–528.
18.
Bergman I, Loxley R: Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 1963;35:1961–1965.
19.
Rojkind M, Gonzales E: An improved method for determining specific radio-activities of proline-14C and hydroxyproline-14C in collagen and in noncollagenous proteins. Ann Biochem 1974;57:1–7.
20.
Beldekas JC, Smith B, Gerstenfeld LC, Sonenshein GE, Franzblau C: Effect of 17 beta-oestradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry 1981;20:2162–2167.
21.
Kern P, Moczar M, Robert L: Biosynthesis of skin collagens in normal and diabetic mice. Biochem J 1979;182:337–345.
22.
Laemmli U: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970;227:680–685.
23.
Stücker M, Krey T, Röchling A, Schultz-Ehrenburg U, Altmeyer P: The histomorphologic changes at the saphenofemoral junction in varicosis of the greater saphenous vein. J Vasc Dis 2000;29:41–46.
24.
Badier-Commander C, Couvelard A, Henin D, Verbeuren TJ, Michel JB, Jacob MP: Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 2001;193:398–407.
25.
Shiraishi M, Segawa M, Takebayashi S: An electron microscopic study on aging of collagenous fibrils in the large blood vessels of humans. J Electron Microsc 1980;29:139–143.
26.
Svejcar J, Prerovsky I, Linhart J, Kruml J: Content of collagen, elastin and water in walls of the internal saphenous vein in man. Circ Res 1962;11:296–300.
27.
Parry DAD: The molecular and fibrillar structure of collagen and its relationship to the mechanical properties of connective tissue. Biophys Chem 1988;29:195–209.
28.
Notbohm H, Mosler S, Müller PK, Brinckmann J: In vitro formation and aggregation of heterotypic collagen I and III fibrils. Int J Biol Macromol 1993;15:299–304.
29.
Fleischmayer R, Perlish JS, Burgeson RE, Shaikh-Bahai F, Timpl R: Type I and type III collagen interactions during fibrillogenesis. Ann NY Acad Sci 1990;580:161–175.
30.
Birk DE, Fitch JM, Babiarz JP, Doane KJ, Linsenmayer TF: Collagen fibrillogenesis in vitro: Interactions of types I and V collagen regulate fibril diameter. J Cell Sci 1990;95:649–657.
31.
Lees TA, Mantle D, Lambert D: A comparison of smooth muscle derived proteolytic enzymes in normal and varicose veins. Phlébologie 1992;92:49–51.
32.
Thakker-Varia S, Anderson DW, Kuivaniemi H, Tromp G, Shin HG, van der Rest M, Glorieux FH, Ala-Kokko L, Stolle CA: Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV. Hum Mutation 1995;6:116–125.
33.
Liau G, Yamada Y, de Combrugghe B: Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. J Biol Chem 1985;260:531–536.
34.
Miskulin M, Dalgleish R, Kluve-Beckerman B, Rennard SI, Tolstoshev P, Brantly M, Crystal RG: Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry 1986;25:1408–1413.
35.
Pinnell SR: Regulation of collagen synthesis. J Invest Dermatol 1982;79(suppl 1):73s–76s.
36.
Seyer JM, Hutcheson ET, Kang AH: Collagen polymorphism in idiopathic pulmonary fibrosis. J Clin Invest 1976;57:1498–1507.
37.
Seyer JM, Hutcheson ET, Kang AH: Collagen polymorphism in normal and cirrhotic liver. J Clin Invest 1977;59:241–244.
38.
Shepherd JT, Vanhoutte PM: The human cardiovascular system, facts and concepts. New York, Raven Press, 1979, pp 1–351.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.